A proactive, results-oriented, life sciences and finance executive with a proven track record of cultivating relationships with strategic partners and within the investment community. Demonstrated ability to leverage corporate finance knowledge and life sciences experience to formulate and execute investor relations and business development strategies/ transactions. Successfully worked on 30 strategic and financing transactions representing more than $13.4 billion.
